Institutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation A Cohort Study

被引:33
作者
Ranasinghe, Isuru [1 ,2 ,11 ]
Labrosciano, Clementine [3 ,11 ]
Horton, Dennis [1 ,4 ,11 ]
Ganesan, Anand [5 ,6 ]
Curtis, Jeptha P. [7 ,8 ,12 ]
Krumholz, Harlan M. [9 ,10 ,12 ]
McGavigan, Andrew [5 ,6 ]
Hossain, Sadia [1 ,11 ]
Air, Tracy [3 ,11 ]
Hariharaputhiran, Saranya [1 ,11 ]
机构
[1] Univ Adelaide, Basil Hetzel Inst Translat Res, Adelaide, SA, Australia
[2] Cent Adelaide Local Hlth Network, Adelaide, SA, Australia
[3] Univ Adelaide, Adelaide, SA, Australia
[4] Data Decis Cooperat Res Ctr, Adelaide, SA, Australia
[5] Flinders Univ S Australia, Adelaide, SA, Australia
[6] Flinders Med Ctr, Adelaide, SA, Australia
[7] Yale New Haven Med Ctr, 20 York St, New Haven, CT 06504 USA
[8] Yale Sch Med, New Haven, CT USA
[9] Yale Sch Med, Yale New Haven Hosp, New Haven, CT USA
[10] Yale Univ, New Haven, CT USA
[11] Basil Hetzel Inst, DX 465701,28 Woodville Rd, Woodville South, SA 5011, Australia
[12] Ctr Outcomes Res & Evaluat, 1 Church St,Suite 200, New Haven, CT 06510 USA
关键词
CARDIOVERTER-DEFIBRILLATOR IMPLANTATION; COMPLICATIONS; PACEMAKER; RISK; MORTALITY; SAFETY; VOLUME;
D O I
10.7326/M18-2810
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cardiovascular implantable electronic devices (CIEDs) are associated with procedure-related complications, yet little is known about variation in complication rates among institutions that may suggest disparities in care quality. Objective: To assess institutional variation in risk-standardized complication rates (RSCRs) for CIED. Design: Cohort study. Setting: 174 hospitals in Australia and New Zealand, 98 of which implanted at least 25 CIEDs during the study period. Participants: 81 304 patients older than 18 years (mean, 74.7 years [SD, 12.4]; 37.9% female) who received a new CIED (65 711 permanent pacemakers [PPMs] and 15 593 implantable cardioverter-defibrillators [ICDs]) in 2010 to 2015. Measurements: RSCRs and frequencies of major device-related complications during hospitalization or within 90 days of discharge. Results: Of the cohort, 6664 patients (8.2%) had a major complication. Although complication rates were higher for ICDs than PPMs (10.04% vs. 7.76%), 76.5% of all complications were attributable to PPMs (5098 vs. 1566 for ICDs). Among hospitals that implanted at least 25 CIEDs, the median RSCR was 8.1%; how-ever, rates varied from 5.3% to 14.3%, with 22 hospitals identified as having RSCRs that differed significantly from the national average. Similar variation was observed when RSCRs for PPM implantation (n = 96 hospitals) (median RSCR, 7.6% [range, 5.4% to 12.9%]) were considered separately from those for ICD placement (n = 68 hospitals) (median RSCR, 9.7% [range, 6.2% to 16.9%]) and persisted when only elective procedures were assessed (n = 88 hospitals) (median RSCR, 7.4% [range, 4.7% to 13.0%]). Limitation: Possible unmeasured confounding from the use of administrative data. Conclusion: CIED complications are common and vary among hospitals, suggesting institutional variation in CIED care quality. Concerted clinical and policy interventions are needed to address CIED-related complications. These efforts should preferentially target PPMs, because most CIED complications are attributable to these devices.
引用
收藏
页码:309 / +
页数:10
相关论文
共 30 条
[1]   The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating medicare beneficiaries [J].
Al-Khatib, SM ;
Lucas, FL ;
Jollis, JG ;
Malenka, DJ ;
Wennberg, DE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (08) :1536-1540
[2]   Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation [J].
Birnie, David H. ;
Healey, Jeff S. ;
Wells, George A. ;
Verma, Atul ;
Tang, Anthony S. ;
Krahn, Andrew D. ;
Simpson, Christopher S. ;
Ayala-Paredes, Felix ;
Coutu, Benoit ;
Leiria, Tiago L. L. ;
Essebag, Vidal .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (22) :2084-2093
[3]   Efficacy and safety of the subcutaneous implantable cardioverter defibrillator: a systematic review [J].
Chue, Colin Dominic ;
Kwok, Chun Shing ;
Wong, Chun Wai ;
Patwala, Ashish ;
Barker, Diane ;
Zaidi, Amir ;
Mamas, Mamas A. ;
Cunnington, Colin ;
Ahmed, Fozia Z. .
HEART, 2017, 103 (17) :1315-1322
[4]  
Clinical Excellence Commission, 2007, SCI REPORT
[5]  
Curtis J, 2012, HOSP RISK STANDARDIZ
[6]   Antibiotic prophylaxis for permanent pacemaker implantation - A meta-analysis [J].
Da Costa, A ;
Kirkorian, G ;
Cucherat, M ;
Delahaye, F ;
Chevalier, P ;
Cerisier, A ;
Isaaz, K ;
Touboul, P .
CIRCULATION, 1998, 97 (18) :1796-1801
[7]   Public Reporting of Clinical Quality Data An Update for Cardiovascular Specialists [J].
Dehmer, Gregory J. ;
Drozda, Joseph P., Jr. ;
Brindis, Ralph G. ;
Masoudi, Frederick A. ;
Rumsfeld, John S. ;
Slattery, Lara E. ;
Oetgen, William J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (13) :1239-1245
[8]   Developing a Risk Model for In-Hospital Adverse Events Following Implantable Cardioverter-Defibrillator Implantation [J].
Dodson, John A. ;
Reynolds, Matthew R. ;
Bao, Haikun ;
Al-Khatib, Sana M. ;
Peterson, Eric D. ;
Kremers, Mark S. ;
Mirro, Michael J. ;
Curtis, Jeptha P. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (08) :788-796
[9]   Systematic review: Implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction [J].
Ezekowitz, Justin A. ;
Rowe, Brian H. ;
Dryden, Donna M. ;
Hooton, Nicola ;
Vandermeer, Ben ;
Spooner, Carol ;
McAlister, Finlay A. .
ANNALS OF INTERNAL MEDICINE, 2007, 147 (04) :251-262
[10]   A systematic review of ICD complications in randomised controlled trials versus registries: is our 'real-world' data an underestimation? [J].
Ezzat, Vivienne A. ;
Lee, Victor ;
Ahsan, Syed ;
Chow, Anthony W. ;
Segal, Oliver ;
Rowland, Edward ;
Lowe, Martin D. ;
Lambiase, Pier D. .
OPEN HEART, 2015, 2 (01)